Gel-Encapsulated Cell Production via Microfluidic Segmentation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current cell transfection methods, such as lipofection, face efficiency issues due to electrostatic characteristics of commonly used gelation materials like sodium alginate and sodium hyaluronate, and high viscosity of gelators, which reduces the collision frequency between cells and transfection reagents, leading to lower introduction efficiency of nucleic acids into cells.

Innovation Solution

A gel-encapsulated cell production apparatus that generates a first droplet containing a processed cell and a second droplet containing a gelator, which are blended to create a gel-encapsulated cell, utilizing microfluidics and a microchannel chip to enhance transfection efficiency by controlling the gelation process and reducing viscosity-related agitation inefficiencies.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If lipofection is used to introduce nucleic acids into cells, then transfection can be achieved, but the electrostatic characteristics of gelation materials like sodium alginate and sodium hyaluronate decrease the efficiency of introduction

Engineering Contradiction:
Improvetransfection efficiencyVSAvoidelectrostatic interference from gelation materials
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent separates the gelation process from the transfection process by using a two-stage microfluidic approach. First, cells are encapsulated in droplets with transfection reagents. Then, after transfection is complete, the droplets are mixed with gelation solution to form gel beads. This segmentation eliminates electrostatic interference during the critical transfection phase while still providing gel encapsulation benefits for subsequent culture.

Inventive Principle:
Principle #1Segmentation

2Reliability

If high viscosity gelators are used to encapsulate cells, then gelation can be achieved, but agitation efficiency decreases and collision frequency between cells and transfection reagents is reduced

Engineering Contradiction:
Improvegelation effectivenessVSAvoidtransfection efficiency
Core Design Contradiction:
ReliabilityVSProductivity

Solution Approach 1:

The patent performs transfection before gelation by pre-mixing cells with transfection reagents in aqueous droplets. This preliminary action ensures that transfection occurs in a low-viscosity environment where reagents can freely move and collide with cells, maximizing transfection efficiency before the gel matrix is formed.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent divides the process into distinct segments: cell encapsulation in droplets, transfection reagent addition, incubation period for transfection, and finally gelation. This segmentation allows each step to occur under optimal conditions, with transfection happening in liquid phase before gelation locks the cells in place.

Inventive Principle:
Principle #1Segmentation

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The apparatus effectively increases the efficiency of cell transfection by encapsulating cells in a gel, improving the interaction between cells and transfection reagents, thereby enhancing the introduction of nucleic acids into cells while minimizing the limitations posed by traditional gelation methods.

Implementation Method 1

a gel-encapsulated cell generator that is arranged on the base plate, is connected to the first droplet generator and the second droplet generator via a channel, blends the first droplet and the second droplet, and generates a gel-encapsulated cell which is the cell encapsulated in a gel originating in the gelator

Methodology Applied
Scientific EffectGelation: Gel

Data Source

PatentUS20240301338A1Gel-encapsulated cell production apparatus and cell culture system
Publication Date: 2024.09.12 CANON MEDICAL SYST CORP
  • US20240301338A1 patent drawing
  • US20240301338A1 patent drawing
  • US20240301338A1 patent drawing

AI summary

A gel-encapsulated cell production apparatus according to an embodiment has a first droplet generator, a second droplet generator, and a gel-encapsulated cell generator. The first droplet generator generates a first droplet in which a processed cell is encapsulated. The second droplet generator generates a second droplet in which a gelator is encapsulated. The gel-encapsulated cell generator is connected to the first droplet generator and the second droplet generator via a channel, and the gel-encapsulated cell generator blends the first droplet and the second droplet and generates a gel-encapsulated cell, which is the cell encapsulated in a gel originating in the gelator.